Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-15
DOI
10.1038/s41380-021-01093-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions
- (2020) Brendan D. Hare et al. MOLECULAR PSYCHIATRY
- Effect of the dopamine stabilizer (-)-OSU6162 on potentiated incubation of opioid craving after electric barrier-induced voluntary abstinence
- (2020) Ida Fredriksson et al. NEUROPSYCHOPHARMACOLOGY
- Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
- (2020) Matthew E. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protracted Effects of Ketamine Require Immediate Kappa Opioid Receptor Activation and Long‐Lasting Desensitization
- (2020) Moriah L. Jacobson et al. FASEB JOURNAL
- Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: Systematic review and meta-analysis
- (2020) Glenn E. Hunt et al. JOURNAL OF AFFECTIVE DISORDERS
- Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice
- (2020) Yunfei Tan et al. JOURNAL OF AFFECTIVE DISORDERS
- R-(−)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder1
- (2020) J.M. Witkin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Improving translation of animal models of addiction and relapse by reverse translation
- (2020) Marco Venniro et al. NATURE REVIEWS NEUROSCIENCE
- Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder
- (2019) Gihyun Yoon et al. JAMA Psychiatry
- A Word to the Wise About Intranasal Esketamine
- (2019) Alan F. Schatzberg AMERICAN JOURNAL OF PSYCHIATRY
- ( R )‐Ketamine exerts antidepressant actions partly via conversion to ( 2R,6R )‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses
- (2019) Panos Zanos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Opioid–galanin receptor heteromers mediate the dopaminergic effects of opioids
- (2019) Ning-Sheng Cai et al. JOURNAL OF CLINICAL INVESTIGATION
- Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine’s Antidepressant Effect
- (2019) Boris D. Heifets et al. JAMA Psychiatry
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
- (2019) Lijia Chang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
- (2019) Nolan R. Williams et al. MOLECULAR PSYCHIATRY
- High-potency ligands for DREADD imaging and activation in rodents and monkeys
- (2019) Jordi Bonaventura et al. Nature Communications
- Specializations for reward-guided decision-making in the primate ventral prefrontal cortex
- (2018) Elisabeth A. Murray et al. NATURE REVIEWS NEUROSCIENCE
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
- (2018) Yan Yang et al. NATURE
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose
- (2017) Sanders A. McDougall et al. PSYCHOPHARMACOLOGY
- Ketamine use in current clinical practice
- (2016) Mei Gao et al. ACTA PHARMACOLOGICA SINICA
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
- (2016) Jaskaran B. Singh et al. AMERICAN JOURNAL OF PSYCHIATRY
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine: NMDA Receptors and Beyond
- (2016) C. F. Zorumski et al. JOURNAL OF NEUROSCIENCE
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
- (2016) Weili Zhu et al. Neuroscience Bulletin
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors
- (2014) Daniela da Fonseca Pacheco et al. BRAIN RESEARCH
- Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats
- (2014) Todd M. Hillhouse et al. PSYCHOPHARMACOLOGY
- Rapid antidepressant effects and abuse liability of ketamine
- (2014) Chun Yang et al. PSYCHOPHARMACOLOGY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
- (2013) Paul J. Carlson et al. BIOLOGICAL PSYCHIATRY
- Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion
- (2013) Hugo A Tejeda et al. NEUROPSYCHOPHARMACOLOGY
- Brain damages in ketamine addicts as revealed by magnetic resonance imaging
- (2013) Chunmei Wang et al. Frontiers in Neuroanatomy
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Potentiation of μ-opioid receptor-mediated signaling by ketamine
- (2011) Achla Gupta et al. JOURNAL OF NEUROCHEMISTRY
- Opiate versus psychostimulant addiction: the differences do matter
- (2011) Aldo Badiani et al. NATURE REVIEWS NEUROSCIENCE
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro
- (2010) Simone Portmann et al. JOURNAL OF CHROMATOGRAPHY A
- Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
- (2010) Christina L. Nemeth et al. PSYCHOPHARMACOLOGY
- Ketamine self-administration in the rat: evidence for a critical role of setting
- (2010) Maria Teresa De Luca et al. PSYCHOPHARMACOLOGY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Principles of laboratory assessment of drug abuse liability and implications for clinical development
- (2009) Lawrence P. Carter et al. DRUG AND ALCOHOL DEPENDENCE
- Isoflurane Inhibits the Neurotransmitter Release Machinery
- (2009) Bruce E. Herring et al. JOURNAL OF NEUROPHYSIOLOGY
- Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride
- (2009) Mark Slifstein et al. SYNAPSE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now